These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alterations in intracellular messengers mobilized by gonadotropin-releasing hormone in an experimental ovarian tumor. Chamson-Reig A, Pignataro OP, Libertun C, Lux-Lantos VA. Endocrinology; 1999 Aug; 140(8):3573-80. PubMed ID: 10433213 [Abstract] [Full Text] [Related]
3. The role of protein kinases A and C pathways in the regulation of mitogen-activated protein kinase activation in response to gonadotropin-releasing hormone receptor activation. Han XB, Conn PM. Endocrinology; 1999 May; 140(5):2241-51. PubMed ID: 10218977 [Abstract] [Full Text] [Related]
4. Mechanism of gonadotropin-releasing hormone (GnRH)-I and -II-induced cell growth inhibition in ovarian cancer cells: role of the GnRH-I receptor and protein kinase C pathway. Kim KY, Choi KC, Auersperg N, Leung PC. Endocr Relat Cancer; 2006 Mar; 13(1):211-20. PubMed ID: 16601289 [Abstract] [Full Text] [Related]
7. Role of mitogen-activated protein kinase/extracellular signal-regulated kinase cascade in gonadotropin-releasing hormone-induced growth inhibition of a human ovarian cancer cell line. Kimura A, Ohmichi M, Kurachi H, Ikegami H, Hayakawa J, Tasaka K, Kanda Y, Nishio Y, Jikihara H, Matsuura N, Murata Y. Cancer Res; 1999 Oct 15; 59(20):5133-42. PubMed ID: 10537288 [Abstract] [Full Text] [Related]
8. Endogenous RGS protein action modulates mu-opioid signaling through Galphao. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways. Clark MJ, Harrison C, Zhong H, Neubig RR, Traynor JR. J Biol Chem; 2003 Mar 14; 278(11):9418-25. PubMed ID: 12524446 [Abstract] [Full Text] [Related]
9. Mechanism of mitogen-activated protein kinase activation by gonadotropin-releasing hormone in the pituitary of alphaT3-1 cell line: differential roles of calcium and protein kinase C. Reiss N, Llevi LN, Shacham S, Harris D, Seger R, Naor Z. Endocrinology; 1997 Apr 14; 138(4):1673-82. PubMed ID: 9075730 [Abstract] [Full Text] [Related]
10. Regulation of adenylyl cyclase, ERK1/2, and CREB by Gz following acute and chronic activation of the delta-opioid receptor. Tso PH, Yung LY, Wong YH. J Neurochem; 2000 Apr 14; 74(4):1685-93. PubMed ID: 10737627 [Abstract] [Full Text] [Related]
13. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase. Tamir A, Granot Y, Isakov N. J Immunol; 1996 Aug 15; 157(4):1514-22. PubMed ID: 8759733 [Abstract] [Full Text] [Related]
14. The galanin receptor type 2 initiates multiple signaling pathways in small cell lung cancer cells by coupling to G(q), G(i) and G(12) proteins. Wittau N, Grosse R, Kalkbrenner F, Gohla A, Schultz G, Gudermann T. Oncogene; 2000 Aug 31; 19(37):4199-209. PubMed ID: 10980593 [Abstract] [Full Text] [Related]
18. Extracellular signal-regulated kinase 1/2 activation by myometrial oxytocin receptor involves Galpha(q)Gbetagamma and epidermal growth factor receptor tyrosine kinase activation. Zhong M, Yang M, Sanborn BM. Endocrinology; 2003 Jul 31; 144(7):2947-56. PubMed ID: 12810550 [Abstract] [Full Text] [Related]
19. Stimulation of Jun N-terminal kinase (JNK) by gonadotropin-releasing hormone in pituitary alpha T3-1 cell line is mediated by protein kinase C, c-Src, and CDC42. Levi NL, Hanoch T, Benard O, Rozenblat M, Harris D, Reiss N, Naor Z, Seger R. Mol Endocrinol; 1998 Jun 31; 12(6):815-24. PubMed ID: 9626657 [Abstract] [Full Text] [Related]